The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

pbp2  -  penicillin-binding protein 2

Staphylococcus aureus RF122

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of pbp2

 

High impact information on pbp2

 

Chemical compound and disease context of pbp2

 

Biological context of pbp2

 

Anatomical context of pbp2

  • The VraS/VraR two-component regulatory system is inducible by cell-wall antimicrobials (beta-lactams, glycopeptides) and controls transcriptional induction of many cell-wall genes including pbp2 and itself [11].
 

Associations of pbp2 with chemical compounds

  • These data demonstrate that although expressions of mecA and pbp2 are required for oxacillin resistance, they are not sufficient [11].
  • It was recently reported that transposon inactivation of pbp2 causes a reduction in methicillin resistance, but complementation experiments were not fully successful [2].
  • With high-resistance strains, flomoxef induced PBP 2' to an extent similar to that of cefazolin in both penicillinase-producing and -negative strains, except for one strain in which the induction did not occur [14].
  • Penicillin-binding protein 2', 2, and 4 fractions were scarcely detectable in MR S. aureus strains grown in the presence of fosfomycin at concentrations of 0.25 MIC and 0.5 MIC, respectively [15].
  • With penicillinase-producing strains of the low-resistance group, cefazolin, cefamandole, and cefmetazole induced PBP 2' production about 5-fold, while flomoxef induced production 2.4-fold or less [14].
 

Analytical, diagnostic and therapeutic context of pbp2

  • Western blot (immunoblot) analysis demonstrated specific binding of the antibodies to PBP2' of a methicillin-resistant S. aureus strain [13].
  • An immunoradiometric assay was developed by using these antibodies for simple detection of PBP2' [13].
  • Experimental proof that this point mutation was responsible for the drug-resistant phenotype, and also for the decreased PBP2 affinity and reduced cell wall cross-linking, was provided by allelic replacement experiments and site-directed mutagenesis [16].
  • One specimen identified as MRSA by susceptibility testing but PBP2' negative by latex agglutination was confirmed as mecA gene negative by PCR [9].
  • The difference in the RT-PCR results among the polyoxometalates suggests that there remain other factors for the inhibition of PBP2' production such as post-transcription process [17].

References

  1. VraSR two-component regulatory system and its role in induction of pbp2 and vraSR expression by cell wall antimicrobials in Staphylococcus aureus. Yin, S., Daum, R.S., Boyle-Vavra, S. Antimicrob. Agents Chemother. (2006) [Pubmed]
  2. Transcriptional analysis of the Staphylococcus aureus penicillin binding protein 2 gene. Pinho, M.G., de Lencastre, H., Tomasz, A. J. Bacteriol. (1998) [Pubmed]
  3. Studies on anti-MRSA parenteral cephalosporins. III. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido-3. Ishikawa, T., Kamiyama, K., Nakayama, Y., Iizawa, Y., Okonogi, K., Miyake, A. J. Antibiot. (2001) [Pubmed]
  4. Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin. Boyle-Vavra, S., Yin, S., Challapalli, M., Daum, R.S. Antimicrob. Agents Chemother. (2003) [Pubmed]
  5. In vitro and in vivo antibacterial activities of OPC-20011, a novel parenteral broad-spectrum 2-oxaisocephem antibiotic. Matsumoto, M., Tamaoka, H., Ishikawa, H., Kikuchi, M. Antimicrob. Agents Chemother. (1998) [Pubmed]
  6. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Moreira, B., Boyle-Vavra, S., deJonge, B.L., Daum, R.S. Antimicrob. Agents Chemother. (1997) [Pubmed]
  7. Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance. Hackbarth, C.J., Kocagoz, T., Kocagoz, S., Chambers, H.F. Antimicrob. Agents Chemother. (1995) [Pubmed]
  8. Increased susceptibility to cephamycin-type antibiotics of methicillin-resistant Staphylococcus aureus defective in penicillin-binding protein 2. Murakami, K., Nomura, K., Doi, M., Yoshida, T. Antimicrob. Agents Chemother. (1987) [Pubmed]
  9. A rapid latex agglutination assay for the detection of penicillin-binding protein 2'. Nakatomi, Y., Sugiyama, J. Microbiol. Immunol. (1998) [Pubmed]
  10. Fosfomycin enhances the expression of penicillin-binding protein 2 in methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains. Najioullah, F., Pellon, G., Freney, J., Michel, G., Fleurette, J. FEMS Microbiol. Lett. (1992) [Pubmed]
  11. The VraS/VraR two-component regulatory system required for oxacillin resistance in community-acquired methicillin-resistant Staphylococcus aureus. Boyle-Vavra, S., Yin, S., Daum, R.S. FEMS Microbiol. Lett. (2006) [Pubmed]
  12. Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in Staphylococcus aureus. Nishi, H., Komatsuzawa, H., Yamada, S., Fujiwara, T., Ohara, M., Ohta, K., Sugiyama, M., Ishikawa, T., Sugai, M. Microbiol. Immunol. (2003) [Pubmed]
  13. Immunological detection of penicillin-binding protein 2' of methicillin-resistant staphylococci by using monoclonal antibodies prepared from synthetic peptides. Saito, M., Sekiguchi, K., Yajima, R., Hina, M., Doss, R.C., Kanno, H. J. Clin. Microbiol. (1995) [Pubmed]
  14. Production of low-affinity penicillin-binding protein by low- and high-resistance groups of methicillin-resistant Staphylococcus aureus. Murakami, K., Nomura, K., Doi, M., Yoshida, T. Antimicrob. Agents Chemother. (1987) [Pubmed]
  15. Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus. Utsui, Y., Ohya, S., Magaribuchi, T., Tajima, M., Yokota, T. Antimicrob. Agents Chemother. (1986) [Pubmed]
  16. Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4, and PBP2A. Łeski, T.A., Tomasz, A. J. Bacteriol. (2005) [Pubmed]
  17. Synergistic effect of polyoxometalates in combination with oxacillin against methicillin-resistant and vancomycin-resistant Staphylococcus aureus: a high initial inoculum of 1 x 108 cfu/ml for in vivo test. Inoue, M., Suzuki, T., Fujita, Y., Oda, M., Matsumoto, N., Iijima, J., Yamase, T. Biomed. Pharmacother. (2006) [Pubmed]
 
WikiGenes - Universities